SPDYC has been identified to be negatively correlated with the outcome of breast cancer and belongs to the speedy/Ringo cyclin-dependent kinase (CDK) family with functions in cell cycle transitions and progression (Cheng and Solomon 2008; Alsaleem et al. 2020). Here, SPDYC is linked to breast carcinoma.